🔎 Trials Near Me

Akèy › Kansè pwostat rezistan a kastasyon › Kalifòni › San Francisco

Etid klinik pou Kansè pwostat rezistan a kastasyon nan San Francisco, CA

3 etid pou Kansè pwostat rezistan a kastasyon ap chèche patisipan nan sit nan ak bò kote San Francisco (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

Ap rekriteFaz 3
  • San Francisco VA Medical Center, San Francisco
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT07164443

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

Ap rekriteFaz 1/2
  • UCSF Medical Center at Mission Bay ( Site 0034), San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT06863272

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

Ap rekriteFaz 1
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Laj 18 a 100 · Gason · Mizajou Aug 13, 2026 · NCT05519449

Etid Kansè pwostat rezistan a kastasyon nan lòt vil

Lòt etid nan San Francisco

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.